Globus Historical Financial Ratios

GMED Stock  USD 51.27  0.02  0.04%   
Globus Medical is recently reporting on over 108 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 1.43 or Days Sales Outstanding of 123 will help investors to properly organize and evaluate Globus Medical financial condition quickly.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

About Globus Financial Ratios Analysis

Globus MedicalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Globus Medical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Globus financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Globus Medical history.

Globus Medical Financial Ratios Chart

Globus Medical financial ratios usually calculated using numerical values taken directly from Globus Medical financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Globus Medical. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
At present, Globus Medical's Days Sales Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 37.12, whereas Operating Cash Flow Per Share is forecasted to decline to 1.18.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Globus Medical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Globus Medical sales, a figure that is much harder to manipulate than other Globus Medical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.
Most ratios from Globus Medical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Globus Medical current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.At present, Globus Medical's Days Sales Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 37.12, whereas Operating Cash Flow Per Share is forecasted to decline to 1.18.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding63.1177.55117.49123.36
PTB Ratio4.184.041.511.43

Globus Medical fundamentals Correlations

0.620.00.14-0.640.120.620.090.620.980.52-0.45-0.430.670.10.27-0.340.650.720.660.00.14-0.220.25-0.410.81
0.62-0.7-0.64-0.47-0.540.02-0.521.00.53-0.020.380.190.23-0.650.13-0.560.030.52-0.13-0.240.3-0.06-0.150.410.36
0.0-0.70.95-0.180.830.270.65-0.70.070.2-0.77-0.480.130.93-0.060.360.350.120.610.030.02-0.030.19-0.770.23
0.14-0.640.95-0.160.880.480.74-0.640.230.43-0.88-0.610.260.970.140.430.530.140.730.18-0.09-0.220.36-0.880.34
-0.64-0.47-0.18-0.16-0.19-0.050.19-0.47-0.540.10.170.36-0.29-0.180.040.44-0.26-0.94-0.280.63-0.71-0.040.240.14-0.64
0.12-0.540.830.88-0.190.360.65-0.540.150.33-0.75-0.57-0.020.90.330.330.330.130.570.040.07-0.380.4-0.740.18
0.620.020.270.48-0.050.360.520.020.710.97-0.72-0.640.680.360.490.140.90.140.840.53-0.4-0.460.77-0.70.53
0.09-0.520.650.740.190.650.52-0.520.190.58-0.77-0.470.140.70.20.770.51-0.080.590.58-0.39-0.170.57-0.780.26
0.621.0-0.7-0.64-0.47-0.540.02-0.520.53-0.020.380.190.23-0.650.13-0.560.030.52-0.13-0.240.3-0.06-0.150.410.36
0.980.530.070.23-0.540.150.710.190.530.61-0.56-0.480.740.170.27-0.210.740.630.720.17-0.04-0.210.34-0.530.86
0.52-0.020.20.430.10.330.970.58-0.020.61-0.67-0.530.570.30.50.260.82-0.010.750.64-0.48-0.460.82-0.660.39
-0.450.38-0.77-0.880.17-0.75-0.72-0.770.38-0.56-0.670.64-0.43-0.81-0.21-0.38-0.76-0.18-0.87-0.420.290.23-0.591.0-0.55
-0.430.19-0.48-0.610.36-0.57-0.64-0.470.19-0.48-0.530.64-0.54-0.66-0.32-0.13-0.73-0.47-0.66-0.070.010.32-0.430.63-0.64
0.670.230.130.26-0.29-0.020.680.140.230.740.57-0.43-0.540.210.0-0.130.680.430.680.23-0.210.00.11-0.40.75
0.1-0.650.930.97-0.180.90.360.7-0.650.170.3-0.81-0.660.210.120.40.420.190.650.07-0.01-0.190.25-0.810.34
0.270.13-0.060.140.040.330.490.20.130.270.5-0.21-0.320.00.120.020.370.030.230.19-0.1-0.970.67-0.210.09
-0.34-0.560.360.430.440.330.140.77-0.56-0.210.26-0.38-0.13-0.130.40.020.15-0.380.040.66-0.540.020.32-0.42-0.03
0.650.030.350.53-0.260.330.90.510.030.740.82-0.76-0.730.680.420.370.150.350.820.4-0.3-0.330.69-0.750.71
0.720.520.120.14-0.940.130.14-0.080.520.63-0.01-0.18-0.470.430.190.03-0.380.350.35-0.540.65-0.02-0.2-0.150.75
0.66-0.130.610.73-0.280.570.840.59-0.130.720.75-0.87-0.660.680.650.230.040.820.350.26-0.13-0.260.52-0.850.62
0.0-0.240.030.180.630.040.530.58-0.240.170.64-0.42-0.070.230.070.190.660.4-0.540.26-0.95-0.110.62-0.450.09
0.140.30.02-0.09-0.710.07-0.4-0.390.3-0.04-0.480.290.01-0.21-0.01-0.1-0.54-0.30.65-0.13-0.950.04-0.50.320.0
-0.22-0.06-0.03-0.22-0.04-0.38-0.46-0.17-0.06-0.21-0.460.230.320.0-0.19-0.970.02-0.33-0.02-0.26-0.110.04-0.620.23-0.05
0.25-0.150.190.360.240.40.770.57-0.150.340.82-0.59-0.430.110.250.670.320.69-0.20.520.62-0.5-0.62-0.60.14
-0.410.41-0.77-0.880.14-0.74-0.7-0.780.41-0.53-0.661.00.63-0.4-0.81-0.21-0.42-0.75-0.15-0.85-0.450.320.23-0.6-0.53
0.810.360.230.34-0.640.180.530.260.360.860.39-0.55-0.640.750.340.09-0.030.710.750.620.090.0-0.050.14-0.53
Click cells to compare fundamentals

Globus Medical Account Relationship Matchups

Globus Medical fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio7.438.157.597.33.844.16
Ptb Ratio4.164.274.184.041.511.43
Days Sales Outstanding75.4968.5163.1177.55117.49123.36
Book Value Per Share14.1415.2817.2918.3835.3537.12
Free Cash Flow Yield0.02880.01730.0210.03020.0140.0355
Operating Cash Flow Per Share1.732.022.741.782.151.18
Stock Based Compensation To Revenue0.03320.03430.03190.03210.03360.0178
Capex To Depreciation(1.34)(1.01)(0.81)(1.08)(0.54)(0.57)
Pb Ratio4.164.274.184.041.511.43
Ev To Sales7.197.857.397.153.884.0
Roic0.09510.05670.07750.09630.02230.0212
Net Income Per Share1.61.571.041.481.890.9
Days Of Inventory On Hand398.14384.62361.61413.79564.73592.96
Payables Turnover6.167.3111.9510.99.676.42
Research And Ddevelopement To Revenue0.07650.110.10.07140.07910.0616
Cash Per Share3.473.144.334.44.444.58
Pocfratio33.9532.3426.3341.8124.7519.58
Interest Coverage(9.88)7.9918.516.026.616.94
Pfcf Ratio57.6747.5833.1571.4636.4750.48
Days Payables Outstanding49.9230.5633.549.9637.7352.94
Income Quality1.111.941.850.941.981.05
Ev To Operating Cash Flow32.8231.1625.6441.024.9718.02
Pe Ratio37.6162.8648.7539.2449.0525.09
Ev To Free Cash Flow55.7645.8432.370.0836.827.02
Earnings Yield0.02660.01590.02050.02550.02040.0194
Intangibles To Total Assets0.190.160.140.130.460.49
Net Debt To E B I T D A(0.62)(0.84)(1.28)(0.46)0.130.14
Current Ratio6.566.176.86.184.887.28
Tangible Book Value Per Share12.0512.8114.8215.7814.4915.22
Receivables Turnover4.845.335.784.713.116.09
Graham Number22.3218.8924.027.9829.430.87
Shareholders Equity Per Share14.1415.2817.2918.3835.3537.12

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
Note that the Globus Medical information on this page should be used as a complementary analysis to other Globus Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for Globus Stock analysis

When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Managers
Screen money managers from public funds and ETFs managed around the world
Is Globus Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.79)
Earnings Share
1.07
Revenue Per Share
13.87
Quarterly Revenue Growth
1.246
Return On Assets
0.0477
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.